To see the Zacks Industry Rank and the trend in earnings estimates revisions for more than 200 industry groups, visit http://at.zacks.com/?id=3154.
Zacks Industry Rank Analysis is written by Charles Rotblut, CFA, Senior Market Analyst for Zacks.com.
This week: Q3 Earnings -- Where to Look for Growth
Key points:
-- Third-quarter earnings for the S&P 500 are projected to decline 5.4%
-- Conversely, nearly 60% of S&P 500 companies should report year-over-growth
-- Investors should therefore be selective about what stocks they buy and own
-- Companies likely to report growth include BDX, GD, ISRG, LLL and SII
Third-quarter earnings season officially started on Tuesday afternoon. Much like the second quarter, it will be a glass half empty versus a glass half full scenario.
At the index level, profits will decline. Our bottom-up analysis projects a 5.4% drop in S&P 500 earnings.
Conversely, nearly 60% of S&P 500 companies should report year-over-year growth. The median company is forecast to report a 5.9% increase in profits. If a majority of companies top expectations, median profit growth could be in the high single digits. Not tremendous growth, but good enough given the current economic backdrop.
The key takeaway for investors is to remain selective about what stocks you buy. Given the current level of volatility, a preference towards companies with a lower level of economic sensitivity and/or a margin of error in expected business conditions would be rewarded.
Medical Products
The entire medical sector often gets a second look by investors during periods of economic uncertainty. The good news for growth investors is that many medical product companies are expected to report double-digit year-over-year increases in profits.
Becton Dickinson (NYSE: BDX | Quote | Chart | News | PowerRating) is a good example. The company produces syringes, among other products. Diabetes care is a big market for the company.
The consensus earnings estimate calls for BDX to report a profit of $1.12 per share, representing year-over-year growth of 14%. This Zacks #2 Rank ("buy") stock has exceeded expectations every quarter for more than 5 years.
BDX is classified in Medical/Dental-Supplies (http://at.zacks.com/?id=4889).
Another option for growth investors is Intuitive Surgical (Nasdaq: ISRG). This company manufactures robotic surgical systems, which are used in the treatment of prostate cancer, kidney cancer, bladder cancer and other diseases.
ISRG is expected to generate profit growth in excess of 30%. Third-quarter earnings are forecast at $1.27 per share. Like BDX, ISRG is a Zacks #2 Rank stock that has a lengthy history of exceeding profit expectations.
ISRG is classified in Medical Instruments (http://at.zacks.com/?id=4890).
Aerospace and Defense
Regardless of who the next president will be, defense spending is unlikely to be curtailed. As a result, companies that rely heavily on the government should continue to do well. Examples include General Dynamics (NYSE: GD | Quote | Chart | News | PowerRating) and L-3 Communications (NYSE: LLL).
GD provides information systems, combat vehicles and submarines. Brokerage analysts project the company to have earned $1.49 last quarter, an 11.2% increase from a year ago. GD has exceeded expectations during 3 out of the last 4 quarters.
LLL supplies products and systems used in aerospace and defense platforms. Many know the company for its secure communication network systems, though it also provides many other products and services.
Forecasts call for the company to have earned $1.71 per share last quarter, which would be a 9.4% increase. The company has exceeded profit expectations for 8 consecutive quarters.
Both GD and LLL are Zacks #2 Rank stocks and are classified in Electronics-Military (http://at.zacks.com/?id=4888).
Oilfield Machinery and Services
Concern about weakening demand for oil has caused many energy-related stocks to fall significantly over the past few weeks. The downward pressure as it relates to oilfield machinery and service stocks (http://at.zacks.com/?id=4675), however, has been irrational.
Here's why. As long as oil stays above $65 per barrel, oil companies will continue to invest in getting Texas Tea out of the ground, as well as spend on infrastructure and maintenance. Therefore, business conditions for oilfield machinery and service companies should remain favorable for the foreseeable future.
One good example is Smith International (NYSE: SII). SII provides a full range of drilling products and services from the rig floor to the drill bit.
Ahead of the company's third-quarter report, 3 of the 16 covering brokerage analysts have raised their profit forecasts. The consensus third-quarter earnings estimate of $1.01 is 22% higher than what the company earned a year ago. SII topped expectations last quarter by 2 cents per share.
SII is a Zacks #2 Rank stock.
Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of the industries and the stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2564.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3:1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit From the Pros by going to http://at.zacks.com/?id=2565.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
SOURCE: Zacks.com
Zacks.com Charles Rotblut, CFA Phone: 312-265-9352 Email: pr@zacks.com Visit: www.Zacks.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index